TrialsgrambetaRCTs are beautiful

ANGEL-ASPECT

2023

Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct

In 456 Chinese patients with LVO and large ischaemic core, endovascular therapy improved the 90-day mRS distribution versus medical management.

Result

Efficacy: mRS shift at 90 daysGeneralised OR 1.37 (95% CI 1.11-1.69) · P = 0.004

Below 1 favours medical management, above 1 favours endovascular therapy.

Event rates

The estimate refers to a different reading of the endpoint than the rates.

Original publication
Subtopic
Large-core thrombectomy
Design
Multicentre RCT, China
Relevance
Supporting: context rather than must-know.
Source
Huo X, et al. N Engl J Med. 2023;388(14):1272-1283.doi 10.1056/NEJMoa2213379

Discussion & critique

Confirms SELECT2: large-core trials redefine the lower limit of viable tissue.